Nonpneumatic Antishock Garment
PATH
Solution Overview & Benefits
The Nonpneumatic Antishock Garment (NASG) is a first-aid medical device designed to stabilize women experiencing severe obstetric hemorrhage, often due to postpartum bleeding or other complications during childbirth. Made from neoprene and featuring Velcro fasteners, the garment is wrapped tightly around the lower body to apply external pressure, redirecting blood flow to vital organs such as the heart, lungs, and brain. This helps to buy time and prevent shock while the patient is transported to receive definitive medical treatment.
Benefits:
- Rapid Stabilization: The NASG helps to quickly stabilize women by controlling severe bleeding and preventing shock, reducing maternal mortality and morbidity.
- Low Cost and Reusability: It is a low-cost, reusable solution that can be disinfected and used for multiple patients, making it suitable for resource-limited settings.
- Ease of Use: The garment can be easily applied by healthcare workers, even those with minimal training, which is essential during emergency situations.
- Portability: Lightweight and compact, the NASG can be easily transported and used in hospitals, clinics, or in the field, enhancing access to emergency care in remote areas.
- Reduced Blood Loss: It helps to reduce blood loss, giving patients a better chance of survival until they can reach a health facility for further treatment.
- Versatility: The NASG can be used for other forms of hypovolemic shock beyond postpartum hemorrhage, broadening its application in emergency care.
Overall, the NASG is a life-saving device that is particularly beneficial in reducing maternal deaths, especially in low-resource environments where immediate access to advanced medical care is limited.
History & Development
PATH has worked with collaborators from the University of California, San Francisco; Pathfinder International; and Blue Fuzion Group to establish high-quality manufacturing for the garment, reduce its price, increase production, and expand access in low-resource settings.
PATHS's mission is to advance health equity through innovation and partnerships.
PATH developed an ID adapter in partnership with SID Technologies LLC, advancing it forward from the initial concept stage through the manufacture of clinic-ready devices.
As part of this effort, we modified and tested successive design prototypes, incorporating feedback from health care workers in the United States and India.
The design was transferred to commercial partner West Pharmaceutical Services, Inc., which is working with a syringe manufacturer (Helm Medical) on regulatory clearance, manufacturing, and distribution.
Clinical trials and pilot studies have demonstrated safety, efficacy, usability, and health care worker preference for the ID adapter for fIPV, and WHO has purchased a supply of 4 million devices for use by countries interested in introducing fractional dose delivery.
Availability
- Publicly available: yes
- Countries where available: Worldwide
- Price range (USD): Contact supplier for quote
Similar solutions...
Get in Touch!
Get in touch with us by filling out the form or emailing us at contact@techxlab.org.
